$CANB
Can B Corp Stock $canb

$canb Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000149315223042109 Filed on November 20, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q4
Revenue	$376.9K	$419.0K	$666.1K
YoY Change	-43.42%	-85.49%	-66.44%
Cost Of Revenue	-$897.6K	$1.236M	$820.8K
YoY Change	-209.35%	20.06%	11.61%
Gross Profit	$1.274M	-$816.7K	-$154.8K
YoY Change	-923.58%	-143.93%	-112.39%
Gross Profit Margin	338.16%	-194.93%	-23.23%
Selling, General & Admin	$4.749M	$2.762M	$12.62M
YoY Change	-62.36%
% of Gross Profit	372.6%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$350.0K	$351.2K	$349.5K
YoY Change	0.15%	0.49%	31.87%
% of Gross Profit	27.46%
Operating Expenses	$1.926M	$2.762M	$2.435M
YoY Change	-20.89%	-68.21%	-47.22%
Operating Profit	-$651.7K	-$3.578M	-$2.590M
YoY Change	-74.83%	-47.59%	-23.01%
Interest Expense	-$1.175M	$585.4K	-$306.8K
YoY Change	283.03%	252.68%	-53.06%
% of Operating Profit
Other Income/Expense, Net	$20.69K	-$587.2K	-$2.300K
YoY Change	-999.57%	789.53%	-3933.33%
Pretax Income	-$1.806M	-$4.165M	-$2.899M
YoY Change	-37.69%	-39.58%	-27.84%
Income Tax	$0.00		$790.00
% Of Pretax Income
Net Earnings	-$1.806M	-$4.165M	-$2.899M
YoY Change	-37.71%	-39.58%	-27.82%
Net Earnings / Revenue	-479.2%	-994.23%	-435.3%
Basic Earnings Per Share		-$0.36
Diluted Earnings Per Share	-$0.06	-$0.36	-$0.70
COMMON SHARES
Basic Shares Outstanding	26.25M shares	9.614M shares	4.047M shares
Diluted Shares Outstanding		11.59M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$34.01K	$31.32K	$73.19K
YoY Change	-53.53%	-9.14%	-83.7%
Cash & Equivalents	$34.01K	$31.32K	$73.19K
Short-Term Investments
Other Short-Term Assets	$4.140K	$29.14K	$21.02K
YoY Change	-80.3%	61.8%	1189.57%
Inventory	$1.620M	$959.7K	$2.024M
Prepaid Expenses
Receivables	$3.723M	$6.613M	$6.586M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$5.381M	$7.633M	$8.704M
YoY Change	-38.18%	-18.38%	30.82%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.401M	$4.453M	$5.432M
YoY Change	-18.98%	-22.94%	-22.98%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$248.6K	$13.14K	$13.14K
YoY Change	1791.77%	0.0%	0.0%
Total Long-Term Assets	$4.745M	$5.443M	$6.855M
YoY Change	-30.78%	-26.13%	-30.2%
TOTAL ASSETS
Total Short-Term Assets	$5.381M	$7.633M	$8.704M
Total Long-Term Assets	$4.745M	$5.443M	$6.855M
Total Assets	$10.13M	$13.08M	$15.56M
YoY Change	-34.92%	-21.79%	-5.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.945M	$4.047M	$3.140M
YoY Change	-38.06%	30.51%	169.96%
Accrued Expenses	$254.4K	$595.9K	$181.7K
YoY Change	40.01%	228.0%	-92.45%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$8.569M	$7.842M	$7.951M
YoY Change	7.78%	7.96%	63.41%
Total Short-Term Liabilities	$11.13M	$12.86M	$12.42M
YoY Change	-10.43%	11.25%	31.29%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$0.00	$0.00	$438.1K
YoY Change	-100.0%	-100.0%	-68.53%
Total Long-Term Liabilities	$0.00		$438.1K
YoY Change	-100.0%		-68.53%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.13M	$12.86M	$12.42M
Total Long-Term Liabilities	$0.00		$438.1K
Total Liabilities	$11.13M	$12.86M	$12.86M
YoY Change	-13.48%	5.16%	18.49%
SHAREHOLDERS EQUITY
Retained Earnings	-$102.4M	-$100.6M	-$92.69M
YoY Change	10.51%	12.06%	19.19%
Common Stock	$83.26M	$82.68M	$79.61M
YoY Change	4.58%	5.31%	60.27%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$572.7K	$572.7K	$572.7K
YoY Change	0.0%	0.0%	0.0%
Treasury Stock Shares
Shareholders Equity	-$1.002M	$219.6K	$2.698M
YoY Change
Total Liabilities & Shareholders Equity	$10.13M	$13.08M	$15.56M
YoY Change	-34.92%	-21.79%	-5.55%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q4
OPERATING ACTIVITIES
Net Income	-$1.806M	-$4.165M	-$2.899M
YoY Change	-37.71%	-39.58%	-27.82%
Depreciation, Depletion And Amortization	$350.0K	$351.2K	$349.5K
YoY Change	0.15%	0.49%	31.87%
Cash From Operating Activities	$151.4K	-$206.6K	-$526.5K
YoY Change	-128.76%	-80.58%	-58.18%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	$0.00
YoY Change			-100.0%
Acquisitions
YoY Change
Other Investing Activities	$370.00	$0.00	$0.00
YoY Change			-100.0%
Cash From Investing Activities	$370.00	$0.00	$0.00
YoY Change			-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-149.1K	114.5K	565.2K
YoY Change	-126.38%	-88.25%	-67.29%
NET CHANGE
Cash From Operating Activities	151.4K	-206.6K	-526.5K
Cash From Investing Activities	370.0	0.000	0.000
Cash From Financing Activities	-149.1K	114.5K	565.2K
Net Change In Cash	2.680K	-92.12K	38.73K
YoY Change	-93.08%	2.84%	-85.02%
FREE CASH FLOW
Cash From Operating Activities	$151.4K	-$206.6K	-$526.5K
Capital Expenditures	$0.00	$0.00	$0.00
Free Cash Flow	$151.4K	-$206.6K	-$526.5K
YoY Change	-128.76%	-80.58%	-55.87%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001509957
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent		usd
CY2023Q3	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans		usd
CY2022Q4	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans		usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2023Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent		usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Other Income OtherIncome		usd
	us-gaap	Other Income OtherIncome		usd
	us-gaap	Other Income OtherIncome		usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
	CANB	Stockbased Wages And Salaries StockbasedWagesAndSalaries		usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
	CANB	Loss On Sale Of Property Plant Equipment LossOnSaleOfPropertyPlantEquipment		usd
	CANB	Cancellation Of Debt CancellationOfDebt		usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
	CANB	Payments For Deposit PaymentsForDeposit		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	CANB	Issuance Of Common Stock In Lieu Of Repayments Of Notes Payable IssuanceOfCommonStockInLieuOfRepaymentsOfNotesPayable		usd
	CANB	Issuance Of Common Stock In Acquisition Of Note Payable Commitment Shares IssuanceOfCommonStockInAcquisitionOfNotePayableCommitmentShares		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	CANB	Conversion Of Series Preferred Stock To Common Stock ConversionOfSeriesPreferredStockToCommonStock		usd
	CANB	Conversion Of Series Preferred Stock To Common Stock ConversionOfSeriesPreferredStockToCommonStock		usd
	CANB	Issuance Of Common Stock Resulting From Exercise Of Warrants IssuanceOfCommonStockResultingFromExerciseOfWarrants		usd
	CANB	Issuance Of Common Stock Warrants And Commitment Shares In Connection With Convertible Promissory Note IssuanceOfCommonStockWarrantsAndCommitmentSharesInConnectionWithConvertiblePromissoryNote		usd
CY2021Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure		usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-55753
	dei	Entity Registrant Name EntityRegistrantName	Can B Corp.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-3624118
	dei	Entity Address Address Line1 EntityAddressAddressLine1	960 South Broadway
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 120
	dei	Entity Address City Or Town EntityAddressCityOrTown	Hicksville
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	11801
	dei	City Area Code CityAreaCode	516
	dei	Local Phone Number LocalPhoneNumber	595-9544
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	26246850	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	31318	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	73194	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1023759	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	985082	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6612539	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6586210	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	959706	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	2024053	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	29139	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	21024	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	7632702	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	8704481	usd
CY2023Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	235787	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	165787	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	98144	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	107144	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4453317	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5432357	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	642341	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1136883	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13139	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13139	usd
CY2023Q3	us-gaap	Other Assets OtherAssets	5442728	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	6855310	usd
CY2023Q3	us-gaap	Assets Assets	13075430	usd
CY2022Q4	us-gaap	Assets Assets	15559791	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4047337	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.08
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3322108	usd
CY2023Q3	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	7841799	usd
CY2022Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	7951196	usd
CY2023Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	22575	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	203043	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	595874	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	652172	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	12855828	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12423762	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	438104	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	438104	usd
CY2023Q3	us-gaap	Liabilities Liabilities	12855828	usd
CY2022Q4	us-gaap	Liabilities Liabilities	12861866	usd
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q3	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2022Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1500000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26246850	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26246850	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4422584	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4422584	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	82678638	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	79614986	usd
CY2023Q3	CANB	Common Stock Issuable No Par Value CommonStockIssuableNoParValue	0
CY2022Q4	CANB	Common Stock Issuable No Par Value CommonStockIssuableNoParValue	0
CY2023Q3	CANB	Common Stock Issuable Shares CommonStockIssuableShares	36248
CY2022Q4	CANB	Common Stock Issuable Shares CommonStockIssuableShares	36248
CY2023Q3	CANB	Common Stock Issuable Value CommonStockIssuableValue	119586	usd
CY2022Q4	CANB	Common Stock Issuable Value CommonStockIssuableValue	119586	usd
CY2023Q3	us-gaap	Treasury Stock Value TreasuryStockValue	572678	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	572678	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10396274	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	8006822	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-100622261	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-92690834	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	219602	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2697925	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13075430	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15559791	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	418957	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2888124	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1778855	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6019446	usd
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.08
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1235647	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1029180	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2694649	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3250327	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	-816690	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	1858944	usd
	us-gaap	Gross Profit GrossProfit	-915794	usd
	us-gaap	Gross Profit GrossProfit	2769119	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	2761523	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	8686912	usd
	us-gaap	Operating Expenses OperatingExpenses	5918933	usd
	us-gaap	Operating Expenses OperatingExpenses	14347703	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3578213	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-6827968	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6834727	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-11578584	usd
CY2022Q3	us-gaap	Other Income OtherIncome	9	usd
CY2022Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-103951	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-180468	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-218039	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	585417	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	165993	usd
	us-gaap	Interest Expense InterestExpense	1335799	usd
	us-gaap	Interest Expense InterestExpense	659394	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1747	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3975	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	68227	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4820	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-587164	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-66008	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1087104	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-446175	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4165377	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6893976	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7921831	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12024759	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9596	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-4165377	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-6893976	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7931427	usd
	us-gaap	Net Income Loss NetIncomeLoss	-12024759	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.98
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.98
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.56
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.56
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11589937	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11589937	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3488903	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3488903	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7358006	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7358006	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3378577	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3378577	shares
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	554887	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	321887	usd
CY2023Q3	CANB	Stock Issued During Period Value Purchase Of Inventory StockIssuedDuringPeriodValuePurchaseOfInventory	175500	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	7792	usd
CY2023Q3	CANB	Stock Issued During Period Value In Lieu Note Repayments StockIssuedDuringPeriodValueInLieuNoteRepayments	1029942	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	589216	usd
CY2023Q3	CANB	Issuance Of Common Stock In Lieu Of Interest Payment IssuanceOfCommonStockInLieuOfInterestPayment	254090	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1451665	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-4165377	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	219602	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	5639653	usd
CY2022Q3	CANB	Stock Issued During Period Value Preferred Stock StockIssuedDuringPeriodValuePreferredStock	2693041	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1246184	usd
CY2022Q3	CANB	Issuance Of Common Stock Resulting From Exercise Of Warrants IssuanceOfCommonStockResultingFromExerciseOfWarrants	8641	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1800000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-6893976	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	4493543	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2697925	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	917694	usd
	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	46875	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	937787	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	589216	usd
	CANB	Stock Issued During Period Value Purchase Of Inventory StockIssuedDuringPeriodValuePurchaseOfInventory	175500	usd
	CANB	Issuance Of Common Stock In Lieu Of Interest Payment IssuanceOfCommonStockInLieuOfInterestPayment	296633	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	7792	usd
	CANB	Stock Issued During Period Value In Lieu Note Repayments StockIssuedDuringPeriodValueInLieuNoteRepayments	1029942	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1451665	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7931427	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	219602	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	5619515	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	5619515	usd
	CANB	Stock Issued During Period Value Preferred Stock StockIssuedDuringPeriodValuePreferredStock	2693041	usd
	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	500000	usd
	CANB	Stock Issued During Period Value Issuance Of Common Stock In Lieu Of Note Interest Repayments StockIssuedDuringPeriodValueIssuanceOfCommonStockInLieuOfNoteInterestRepayments	73078	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	3386044	usd
	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	98666	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1767498	usd
	CANB	Issuance Of Common Stock Resulting From Exercise Of Warrants IssuanceOfCommonStockResultingFromExerciseOfWarrants	8641	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2371819	usd
	us-gaap	Net Income Loss NetIncomeLoss	-12024759	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	4493543	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	4493543	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7931427	usd
	us-gaap	Net Income Loss NetIncomeLoss	-12024759	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1451665	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	5064860	usd
	CANB	Stockbased Wages And Salaries StockbasedWagesAndSalaries	589216	usd
	us-gaap	Depreciation Depreciation	1040915	usd
	us-gaap	Depreciation Depreciation	1061549	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	9000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	23906	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	522274	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	324987	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	38631	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	316136	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	252462	usd
	CANB	Loss On Sale Of Property Plant Equipment LossOnSaleOfPropertyPlantEquipment	309000	usd
	CANB	Cancellation Of Debt CancellationOfDebt	-110000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-180468	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-218039	usd
	CANB	Stockbased Interest Expense StockbasedInterestExpense	296633	usd
	CANB	Stockbased Interest Expense StockbasedInterestExpense	73078	usd
	CANB	Stockbased Consulting Expense StockbasedConsultingExpense	917694	usd
	CANB	Stockbased Consulting Expense StockbasedConsultingExpense	3386044	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	64960	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3706157	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1239847	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-294424	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	8115	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	14210	usd
	CANB	Increase Decrease In Lease Right Of Use Asset IncreaseDecreaseInLeaseRightOfUseAsset	-140	usd
	CANB	Increase Decrease In Lease Right Of Use Asset IncreaseDecreaseInLeaseRightOfUseAsset	26536	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	733022	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1462301	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1455933	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3420954	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15000	usd
	CANB	Payments For Deposit PaymentsForDeposit	70000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-85000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2255000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2854853	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	500000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	630943	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	347693	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	178000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	77706	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	53000	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	76970	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1499057	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3006424	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-41876	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-414530	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	73194	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	449001	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	31318	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	34471	usd
	us-gaap	Interest Paid Net InterestPaidNet	72346	usd
	CANB	Issuance Of Common Stock In Lieu Of Repayments Of Notes Payable IssuanceOfCommonStockInLieuOfRepaymentsOfNotesPayable	1029942	usd
	CANB	Issuance Of Common Stock In Acquisition Of Note Payable Commitment Shares IssuanceOfCommonStockInAcquisitionOfNotePayableCommitmentShares	1767498	usd
	us-gaap	Stock Issued1 StockIssued1	46875	usd
	CANB	Debt Discount Associated With Convertible Note DebtDiscountAssociatedWithConvertibleNote	273529	usd
	CANB	Debt Discount Associated With Convertible Note DebtDiscountAssociatedWithConvertibleNote	357049	usd
	CANB	Issuance Of Common Stock Resulting From Exercise Of Warrants IssuanceOfCommonStockResultingFromExerciseOfWarrants	8641	usd
	CANB	Issuance Of Common Stock Warrants And Commitment Shares In Connection With Convertible Promissory Note IssuanceOfCommonStockWarrantsAndCommitmentSharesInConnectionWithConvertiblePromissoryNote	937787	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	31318	usd
CY2023Q3	CANB	Working Capital WorkingCapital	5195758	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7931427	usd
	us-gaap	Net Income Loss NetIncomeLoss	-12024759	usd
CY2023Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	21724	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	21724	usd
CY2023Q3	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	12378	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_845_eus-gaap--UseOfEstimates_zhZuqv833pnl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zlwdmDZnMju4">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses in those financial statements. Certain significant accounting policies that contain subjective management estimates and assumptions include those related to revenue recognition, inventory, goodwill, intangible assets and other long-lived assets, income taxes and deferred taxes. Descriptions of these policies are discussed in the Company’s 2022 Form 10-K. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and adjusts when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from those estimates and assumptions. Significant changes, if any, in those estimates resulting from continuing changes in the economic environment will be reflected in the consolidated financial statements in future periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84B_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zPPxDjDnq7Ni" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_zaLjzpAcE5k1">Reclassifications</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain amounts in the prior year consolidated financial statements have been reclassified to conform to the current year presentation. These reclassification adjustments had no effect on the Company’s previously reported net loss.</span></p>
CY2023Q3	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	22575	usd
CY2022Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	203043	usd
CY2022Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	12378	usd
CY2023Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	6828083	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	6766208	usd
CY2023Q3	CANB	Medical Equipment MedicalEquipment	776396	usd
CY2022Q4	CANB	Medical Equipment MedicalEquipment	776396	usd
	CANB	Issuance Of Warrant Liabilities IssuanceOfWarrantLiabilities	357053	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-218039	usd
CY2022Q3	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	130373	usd
CY2022Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	203043	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-180468	usd
CY2023Q3	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	22575	usd
CY2023Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	447206	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	829844	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	512500	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1194209	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	959706	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	2024053	usd
CY2023Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	26902	usd
CY2022Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	26902	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7665483	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7603608	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3212166	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2171251	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4453317	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5432357	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1040915	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1061549	usd
CY2023Q3	CANB	Finite Lived Technology Ip And Patents FiniteLivedTechnologyIpAndPatents	119998	usd
CY2022Q4	CANB	Finite Lived Technology Ip And Patents FiniteLivedTechnologyIpAndPatents	119998	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	119998	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	119998	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	21854	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	12854	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	98144	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	107144	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	9000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	23906	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	3000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	12000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	12000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	12000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	12000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	47144	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	98144	usd
CY2022	CANB	Purchase Amount Of Future Receivables PurchaseAmountOfFutureReceivables	450000	usd
CY2023Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	95000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1056666	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.02
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y6M29D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	11166655	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue	0.12
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y10M17D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	12223331	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.08
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y10M20D
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1451665	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2371819	usd
	us-gaap	Payments For Rent PaymentsForRent	292873	usd
	us-gaap	Payments For Rent PaymentsForRent	595104	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	185557	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	469818	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	655375	usd

Files In Submission

Name	View Source	Status
canb-20230930_pre.xml	Edgar Link	unprocessable
canb-20230930_lab.xml	Edgar Link	unprocessable
0001493152-23-042109-index-headers.html	Edgar Link	pending
0001493152-23-042109-index.html	Edgar Link	pending
0001493152-23-042109.txt	Edgar Link	pending
0001493152-23-042109-xbrl.zip	Edgar Link	pending
canb-20230930.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
canb-20230930_cal.xml	Edgar Link	unprocessable
canb-20230930_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CANB
Can B Corp Stock $canb

2023 Q4 Form 10-Q Financial Statement

#000149315223042109 Filed on November 20, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CANB Can B Corp Stock $canb

2023 Q4 Form 10-Q Financial Statement

#000149315223042109 Filed on November 20, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CANB
Can B Corp Stock $canb